DUSA Pharmaceuticals, Inc.: Investors Exercise Additional Investment Rights.Business Editors/Health/Medical Writers WILMINGTON, Mass.--(BUSINESS WIRE)--April 15, 2004 DUSA DUSA Deputy Under Secretary of the Army DUSA Deakin University Student Association DUSA Dundee University Students' Association (Scotland) DUSA Designated Unclassified Subject Area Pharmaceuticals, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :DUSA) today announced that on April 14th it received exercise notices from all investors in its recently completed private placement relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc the exercise of additional investment rights to purchase 337,500 shares of its common stock at a price of $11.00 per share. The securities to be issued by DUSA have not been registered under the Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. However, as part of the private placement transaction, DUSA has filed a registration statement on Form S-3 with the Securities and Exchange Commission. DUSA Pharmaceuticals, Inc. is a biopharmaceutical company engaged primarily in the development of Levulan(R) Photodynamic Therapy photodynamic therapy n. A type of phototherapy in which a nontoxic light-sensitive compound that has been injected into a patient is exposed selectively to light, whereupon it becomes toxic to targeted malignant and other diseased cells. (PDT PDT abbr. Pacific Daylight Time PDT Pacific Daylight Time PDT n abbr (US) (= Pacific Daylight Time) → hora de verano del Pacífico PDT ) and Photodetection (PD) for multiple medical indications, with its primary focus in dermatology. PDT and PD utilize light-activated compounds such as Levulan(R) to induce a therapeutic or detection effect. DUSA is a world leader in topically or locally applied PDT and PD. The Company maintains offices in Wilmington, MA, Valhalla, NY, and Toronto, Ontario. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion